tiprankstipranks
Trending News
More News >
BioVersys AG (CH:BIOV)
:BIOV
Switzerland Market

Compare BioVersys AG (BIOV) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BioVersys AG
CHF22.60
CHF132.17M
-35.70%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
$3.50
$160.46M
-1.83
-31.24%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF54.20
CHF660.21M
9.07
30.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
$9.36
$615.90M
6.81
0.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
$13.25
$216.75M
-2.24
40.66%
1 Buy
0 Hold
0 Sell
Moderate Buy
RELIEF THERAPEUTICS Holding
$1.88
$260.47M
-1.14
-43.04%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:BIOV
BioVersys AG
22.60
-10.88
-32.50%
MLLCF
Molecular Partners AG
3.50
-1.42
-28.86%
CH:BSLN
Basilea Pharmaceutica
54.20
14.30
35.84%
NWPHF
Newron Pharmaceuticals SpA
9.36
0.00
0.00%
SPHDF
Santhera Pharmaceuticals Holding
13.25
3.83
40.66%
RLFTF
RELIEF THERAPEUTICS Holding
2.42
-1.58
-39.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts